{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:31:01Z","timestamp":1793860261245,"version":"4.6.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jacc.2021.12.016","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T15:06:28Z","timestamp":1645455988000},"page":"819-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":228,"title":["Managing Atherosclerotic Cardiovascular Risk in Young Adults"],"prefix":"10.1016","volume":"79","author":[{"given":"Neil J.","family":"Stone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Sidney C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Orringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Rigotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Navar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiya S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Pencina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Grundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jacc.2021.12.016_bib1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases Writing Group. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jacc.2021.12.016_bib2","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.jacc.2020.10.011","article-title":"Life course developmental approach to cardiovascular health and cardiovascular disease prevention: opportunities and unanswered questions","volume":"76","author":"Vasan","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.12.016_bib3","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.jacc.2020.10.002","article-title":"Associations of late adolescent or young adult cardiovascular health with premature cardiovascular disease and mortality","volume":"76","author":"Perak","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jacc.2021.12.016_bib4","article-title":"Adverse trends in premature cardiometabolic mortality in the United States, 1999 to 2018","volume":"9","author":"Shah","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.jacc.2021.12.016_bib5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.amjmed.2019.10.020","article-title":"Risk factors and outcomes of very young adults who experience myocardial infarction: the Partners YOUNG-MI registry","volume":"133","author":"Yang","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2021.12.016_bib6","series-title":"The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General","year":"2014"},{"key":"10.1016\/j.jacc.2021.12.016_bib7","series-title":"How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General","year":"2010"},{"issue":"4","key":"10.1016\/j.jacc.2021.12.016_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMsa1211128","article-title":"21st-century hazards of smoking and benefits of cessation in the United States","volume":"368","author":"Jha","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.12.016_bib9","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.15585\/mmwr.mm6946a4","article-title":"Tobacco product use among adults\u2014United States, 2019","volume":"69","author":"Cornelius","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacc.2021.12.016_bib10","series-title":"Public Health Consequences of E-Cigarettes. National Academies of Sciences, Engineering and Medicine, Board on Population Health and Public Health Practice, Health and Medicine Division","year":"2018"},{"issue":"25","key":"10.1016\/j.jacc.2021.12.016_bib11","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","article-title":"2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents","volume":"72","author":"Barua","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2021.12.016_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2019.06.003","article-title":"Smoking cessation and cardiovascular disease: it\u2019s never too early or too late for action","volume":"74","author":"Rigotti","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2021.12.016_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2020.25019","article-title":"Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force Recommendation Statement","volume":"325","year":"2021","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.jacc.2021.12.016_bib14","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jacc.2021.12.016_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jacc.2021.12.016_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamacardio.2020.1731","article-title":"Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors","volume":"5","author":"Whelton","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.jacc.2021.12.016_bib17","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1161\/HYP.0000000000000195","article-title":"Management of stage 1 hypertension in adults with a low 10-year risk for cardiovascular disease: filling a guidance gap: a scientific statement from the American Heart Association","volume":"77","author":"Jones","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2021.12.016_bib18","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1161\/CIR.0000000000000618","article-title":"Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association","volume":"139","author":"de Ferranti","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.12.016_bib19","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.12.016_bib20","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.12.016_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.12.016_bib22","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1001\/jama.2019.4984","article-title":"Trends in levels of lipids and apolipoprotein B in US youths aged 6 to 19 years, 1999-2016","volume":"321","author":"Perak","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.12.016_bib23","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Boron","year":"2020","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.jacc.2021.12.016_bib24","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jacc.2020.07.059","article-title":"Time course of LDL cholesterol exposure and cardiovascular disease event risk","volume":"76","author":"Domanski","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.12.016_bib25","article-title":"Age and cardiovascular risk attributable to apolipoprotein b, low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol","volume":"5","author":"Sniderman","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"16","key":"10.1016\/j.jacc.2021.12.016_bib26","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jacc.2015.02.025","article-title":"Using age- and sex-specific risk thresholds to guide statin therapy: one size may not fit all","volume":"65","author":"Navar-Boggan","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25 Pt B","key":"10.1016\/j.jacc.2021.12.016_bib27","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","volume":"63","author":"Goff","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9841","key":"10.1016\/j.jacc.2021.12.016_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jacc.2021.12.016_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11883-020-00884-2","article-title":"The knowns and unknowns of contemporary statin therapy for familial hypercholesterolemia","volume":"22","author":"Pang","year":"2020","journal-title":"Curr Atheroscler Rep"},{"issue":"11","key":"10.1016\/j.jacc.2021.12.016_bib30","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.115.019014","article-title":"Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of West of Scotland Coronary Prevention Study","volume":"133","author":"Ford","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.12.016_bib31","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.115.018791","article-title":"Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)","volume":"133","author":"de Ferranti","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.12.016_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2015.04.809","article-title":"Prevalence and management of familial hypercholesterolaemia in coronary patients: an analysis of EUROASPIRE IV, a study of the European Society of Cardiology","volume":"241","author":"De Backer","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2021.12.016_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2016.03.023","article-title":"Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins","volume":"249","author":"Rallidis","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2021.12.016_bib34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.116.023007","article-title":"Prognosis of patients with familial hypercholesterolemia after acute coronary syndromes","volume":"134","author":"Nanchen","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.12.016_bib35","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.12.016_bib36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jamapediatrics.2015.0168","article-title":"Application of pediatric and adult guidelines for treatment of lipid levels among US adolescents transitioning to young adulthood","volume":"169","author":"Gooding","year":"2015","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jacc.2021.12.016_bib37","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-associated side effects","volume":"67","author":"Thompson","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.12.016_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-511X-10-94","article-title":"Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)","volume":"10","author":"Mata","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacc.2021.12.016_bib39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MOL.0000000000000397","article-title":"Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns","volume":"28","author":"Hopkins","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2021.12.016_bib40","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2021.12.016_bib41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacl.2019.05.005","article-title":"Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit","volume":"13","author":"Robinson","year":"2019","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2021.12.016_bib42","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJMoa1913805","article-title":"Inclisiran for the treatment of heterozygous familial hypercholesterolemia","volume":"382","author":"Raal","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.12.016_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2015.10.055","article-title":"Discordance between apolipoprotein B and LDL-cholesterol in young adults predicts coronary artery calcification: the CARDIA study","volume":"67","author":"Wilkins","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.12.016_bib44","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.12.016_bib45","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/CIRCULATIONAHA.119.041998","article-title":"Association between triglyceride lowering and reduction of cardiovascular risk across multiple lipid-lowering therapeutic classes: a systematic review and meta-regression analysis of randomized controlled trials","volume":"140","author":"Marston","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jacc.2021.12.016_bib46","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"78","author":"Virani","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.12.016_bib47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet DM Endocrinol"},{"issue":"4","key":"10.1016\/j.jacc.2021.12.016_bib48","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.mayocpiqo.2021.03.009","article-title":"Risk factors for premature myocardial infarction: a systematic review and meta\u2013analysis of 77 studies","volume":"5","author":"Dugani","year":"2021","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"4","key":"10.1016\/j.jacc.2021.12.016_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.7073","article-title":"Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women","volume":"6","author":"Dugani","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2021.12.016_bib50","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1373\/clinchem.2016.258897","volume":"62","author":"Nordestgaard","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2021.12.016_bib51","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.12.016_bib52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin)","volume":"129","author":"Khera","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.12.016_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacc.2019.10.057","article-title":"Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome","volume":"75","author":"Bittner","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2021.12.016_bib54","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jacl.2019.04.010","article-title":"Use of lipoprotein(a) in clinical practice: a biomarker whose time has come. A scientific statement from the National Lipid Association","volume":"13","author":"Wilson","year":"2019","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2021.12.016_bib55","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(18)31652-0","article-title":"Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials","volume":"392","author":"Willeit","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jacc.2021.12.016_bib56","first-page":"1129","article-title":"2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2021.12.016_bib57","first-page":"1673","article-title":"The 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guidelines on the management of blood cholesterol in diabetes.","volume":"43","author":"Goldberg","year":"2020","journal-title":"DM Care"},{"key":"10.1016\/j.jacc.2021.12.016_bib58","first-page":"2643","article-title":"DM Control and Complications Trial\/Epidemiology of DM Interventions and Complications (DCCT\/EDIC) Study Research Group. Intensive DM treatment and cardiovascular disease in patients with type 1 DM","volume":"353","author":"Nathan","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jacc.2021.12.016_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-8587(17)30186-9","article-title":"Type 2 diabetes in adolescents and young adults","volume":"6","author":"Lascar","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2021.12.016_bib60","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/pedi.12953","article-title":"Novo Nordisk Pediatric Type 2 Diabetes Global Expert Panel. Rapid progression of type 2 diabetes and related complications in children and young people--a literature review","volume":"21","author":"Barrett","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jacc.2021.12.016_bib61","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.2337\/dc12-2455","article-title":"Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes","volume":"36","author":"Constantino","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2021.12.016_bib62","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.0686","article-title":"Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood","volume":"317","author":"Dabelea","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.12.016_bib63","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11606-015-3556-3","article-title":"Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events","volume":"31","author":"Rana","year":"2016","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2021.12.016_bib64","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2337\/db05-1423","article-title":"The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study Experience","volume":"55","author":"Pambianco","year":"2006","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jacc.2021.12.016_bib65","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1479164112436403","article-title":"Global cardiovascular disease risk assessment in United States adults with diabetes","volume":"9","author":"Wong","year":"2012","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jacc.2021.12.016_bib66","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.amjcard.2017.02.023","article-title":"Presence, characteristics, and volumes of coronary plaque determined by computed tomography angiography in young type 2 diabetes mellitus","volume":"119","author":"Nezarat","year":"2017","journal-title":"Am J Cardiol"},{"issue":"7 Pt 2","key":"10.1016\/j.jacc.2021.12.016_bib67","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jcmg.2019.01.014","article-title":"The association of coronary artery calcification with subsequent incidence of cardiovascular disease in type 1 diabetes: the DCCT\/EDIC trials","volume":"12","author":"Budoff","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"1","key":"10.1016\/j.jacc.2021.12.016_bib68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jacl.2020.12.005","article-title":"The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction","volume":"15","author":"Orringer","year":"2021","journal-title":"J\u00a0Clin Lipidol"},{"issue":"16","key":"10.1016\/j.jacc.2021.12.016_bib69","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.jacc.2021.12.016_bib70","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacc.2021.12.016_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12941","article-title":"Upper body fat predicts metabolic syndrome similarly in men and women","volume":"48","author":"Grundy","year":"2018","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.jacc.2021.12.016_bib72","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies","volume":"49","author":"Gami","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.jacc.2021.12.016_bib73","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2021.12.016_bib74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/dc06-1414","article-title":"The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes","volume":"30","author":"Lorenzo","year":"2007","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.jacc.2021.12.016_bib75","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/eci.12519","article-title":"Adipose tissue and metabolic syndrome: too much, too little or neither","volume":"45","author":"Grundy","year":"2015","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"10.1016\/j.jacc.2021.12.016_bib76","doi-asserted-by":"crossref","first-page":"21630","DOI":"10.1002\/jcp.28821","article-title":"Impact of different ectopic fat depots on cardiovascular and metabolic diseases","volume":"234","author":"Ferrara","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"issue":"14","key":"10.1016\/j.jacc.2021.12.016_bib77","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","article-title":"Bariatric surgery: a systematic review and meta-analysis","volume":"292","author":"Buchwald","year":"2004","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jacc.2021.12.016_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219798","article-title":"Domain and intensity of physical activity are associated with metabolic syndrome: a population-based study","volume":"14","author":"Serrano-S\u00e1nchez","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jacc.2021.12.016_bib79","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/ATVBAHA.107.151092","article-title":"Metabolic syndrome pandemic","volume":"28","author":"Grundy","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2021.12.016_bib80","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ahj.2017.12.005","article-title":"Improving patient risk communication: translating cardiovascular risk into standardized risk percentiles","volume":"198","author":"Navar","year":"2018","journal-title":"Am Heart J"},{"issue":"24","key":"10.1016\/j.jacc.2021.12.016_bib81","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1161\/CIRCULATIONAHA.108.816694","article-title":"Predicting the 30-year risk of cardiovascular disease: the Framingham heart study","volume":"119","author":"Pencina","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacc.2021.12.016_bib82","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1012848","article-title":"Lifetime risks of cardiovascular disease","volume":"366","author":"Berry","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.jacc.2021.12.016_bib83","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/CIRCULATIONAHA.120.045851","article-title":"The expected 30-year benefits of early versus delayed primary prevention of cardiovascular disease by lipid lowering","volume":"142","author":"Pencina","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacc.2021.12.016_bib84","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jacc.2019.04.047","article-title":"Trajectories of non-HDL cholesterol across midlife: implications for cardiovascular prevention","volume":"74","author":"Pencina","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2021.12.016_bib85","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000580","article-title":"Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association","volume":"138","author":"Volgman","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.12.016_bib86","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2021.12.016_bib87","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.2019.21782","article-title":"Predictive accuracy of a polygenic risk score compared with a clinical risk score for incident coronary heart disease","volume":"323","author":"Mosley","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.12.016_bib88","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/jama.2019.22241","article-title":"Predictive accuracy of a polygenic risk score-enhanced prediction model vs a clinical risk score for coronary artery disease","volume":"323","author":"Elliott","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.12.016_bib89","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.116.024436","article-title":"Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting","volume":"135","author":"Natarajan","year":"2017","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.jacc.2021.12.016_bib90","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2021.08.019","article-title":"Modeling the recommended age for initiating coronary artery calcium testing among at-risk young adults","volume":"78","author":"Dzaye","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacc.2021.12.016_bib91","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jcmg.2020.12.007","article-title":"Predicting age of conversion to CAC >0: a role for polygenic risk scores?","volume":"14","author":"Blaha","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.12.016_bib92","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcmg.2019.02.005","article-title":"Long-term all-cause and cause-specific mortality in asymptomatic patients with CAC\u00a0\u22651,000: results from the CAC Consortium","volume":"13","author":"Peng","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"16","key":"10.1016\/j.jacc.2021.12.016_bib93","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.120.050545","article-title":"Very high coronary artery calcium (\u22651000) and association with cardiovascular disease events, non-cardiovascular disease outcomes, and mortality: results from MESA","volume":"143","author":"Peng","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacc.2021.12.016_bib94","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.ATV.21.5.852","article-title":"Prevalence and correlates of coronary calcification in black and white young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"21","author":"Bild","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2021.12.016_bib95","article-title":"Predictors of coronary artery calcium and long-term risks of death, myocardial infarction, and stroke in young adults","volume":"10","author":"Javaid","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.jacc.2021.12.016_bib96","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamacardio.2016.5493","article-title":"Association of coronary artery calcium in adults aged 32 to 46 years with incident coronary heart disease and death","volume":"2","author":"Carr","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2021.12.016_bib97","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jacc.2021.05.011","article-title":"Progression of Early Subclinical Atherosclerosis (PESA) study: JACC focus seminar 7\/8","volume":"78","author":"Ibanez","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.jacc.2021.12.016_bib98","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.290.17.2277","article-title":"Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study","volume":"290","author":"Raitakari","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jacc.2021.12.016_bib99","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006548","article-title":"Patient-perceived versus actual risk of cardiovascular disease and associated willingness to consider and use prevention therapy","volume":"14","author":"Navar","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"10.1016\/j.jacc.2021.12.016_bib100","article-title":"Patient-reported reasons for declining or discontinuing statin therapy: insights from the PALM Registry","volume":"8","author":"Bradley","year":"2019","journal-title":"J\u00a0Am Heart Assoc"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721084448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721084448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:48:16Z","timestamp":1760017696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109721084448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":100,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0735109721084448"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2021.12.016","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing Atherosclerotic Cardiovascular Risk in Young Adults","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2021.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}